By Keith Goldberg ( August 8, 2012, 3:22 PM EDT) -- A pharmaceutical industry group on Tuesday backed Pfizer Inc.'s challenge of a $142 million jury award in multidistrict litigation over off-label marketing of painkiller Neurontin, telling the First Circuit that the verdict could stifle acceptable off-label drug uses and chill scientific discussion....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.